A detailed history of Tectonic Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tectonic Advisors LLC holds 3,342 shares of LLY stock, worth $2.49 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
3,342
Previous 3,338 0.12%
Holding current value
$2.49 Million
Previous $3.02 Million 2.05%
% of portfolio
0.2%
Previous 0.22%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$772.14 - $960.02 $3,088 - $3,840
4 Added 0.12%
3,342 $2.96 Million
Q2 2024

Aug 02, 2024

BUY
$724.87 - $909.04 $2,899 - $3,636
4 Added 0.12%
3,338 $3.02 Million
Q1 2024

May 07, 2024

BUY
$592.2 - $792.28 $1,776 - $2,376
3 Added 0.09%
3,334 $2.59 Million
Q4 2023

Jan 17, 2024

BUY
$525.19 - $619.13 $7,352 - $8,667
14 Added 0.42%
3,331 $1.94 Million
Q3 2023

Oct 23, 2023

BUY
$434.7 - $599.3 $120,846 - $166,605
278 Added 9.15%
3,317 $1.78 Million
Q2 2023

Jul 13, 2023

BUY
$350.74 - $468.98 $3,156 - $4,220
9 Added 0.3%
3,039 $1.43 Million
Q1 2023

Apr 25, 2023

BUY
$310.63 - $364.82 $3,416 - $4,013
11 Added 0.36%
3,030 $1.04 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $1,286 - $1,498
-4 Reduced 0.13%
3,019 $1.1 Million
Q2 2022

Aug 11, 2022

SELL
$278.73 - $327.27 $10,870 - $12,763
-39 Reduced 1.27%
3,023 $980,000
Q4 2021

Feb 02, 2022

SELL
$224.85 - $279.04 $6,070 - $7,534
-27 Reduced 0.87%
3,062 $846,000
Q3 2021

Nov 02, 2021

SELL
$221.6 - $272.71 $26,148 - $32,179
-118 Reduced 3.68%
3,089 $714,000
Q2 2021

Jul 22, 2021

SELL
$180.55 - $233.54 $1,444 - $1,868
-8 Reduced 0.25%
3,207 $736,000
Q1 2021

May 18, 2021

BUY
$164.32 - $212.72 $6,901 - $8,934
42 Added 1.32%
3,215 $601,000
Q4 2020

May 17, 2021

BUY
$130.46 - $172.63 $413,949 - $547,754
3,173 New
3,173 $536,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tectonic Advisors LLC Portfolio

Follow Tectonic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tectonic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tectonic Advisors LLC with notifications on news.